FDA Adverse Event Injury Summary report: N

VITALITY 2

MDR report key: 2172895 · Received July 22, 2011

Report

Report Number
2124215-2011-10488
Event Type
Injury
Date Received
July 22, 2011
Date of Event
June 8, 2011
Report Date
July 14, 2011
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Removal / Correction Number
Z-0047-08 TO Z-0053-08
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

A REVIEW OF DEVICE MEMORY REVEALED THAT THE DEVICE DECLARED END OF LIFE (EOL) AFTER EXPERIENCING ONE CHARGE TIME GREATER THAN 30 SECONDS. THE OBSERVED RATE OF BATTERY USAGE WAS COMPARED TO THE EXPECTED RATE OF BATTERY USAGE; THE RESULTS INDICATED THAT THE MONITORING VOLTAGE WAS NORMAL. ALTHOUGH THE BATTERY ITSELF HAD NOT DEPLETED PREMATURELY, EOL WAS TRIGGERED EARLIER THAN EXPECTED BY EXTENDED CHARGE TIMES DUE TO A HIGHER-THAN-TYPICAL BUILD-UP OF INTERNAL BATTERY IMPEDANCE. THIS DEVICE IS INCLUDED IN THE MID-LIFE DISPLAY OF REPLACEMENT INDICATORS (NOVEMBER 27, 2007) ADVISORY POPULATION.

Additional Manufacturer Narrative · 1

THIS ICD WILL BE RETURNED TO BOSTON SCIENTIFIC FOR LABORATORY ANALYSIS. AT THIS TIME THERE IS NO ADDITIONAL INFORMATION. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE THIS REPORT WILL BE UPDATED.

Additional Manufacturer Narrative · 1

A REVIEW OF DEVICE MEMORY REVEALED THAT THE DEVICE DECLARED END OF LIFE (EOL) AFTER EXPERIENCING ONE CHARGE TIME GREATER THAN 30 SECONDS. THE OBSERVED RATE OF BATTERY USAGE WAS COMPARED TO THE EXPECTED RATE OF BATTERY USAGE; THE RESULTS INDICATED THAT THE MONITORING VOLTAGE WAS NORMAL. ALTHOUGH THE BATTERY ITSELF HAD NOT DEPLETED PREMATURELY, EOL WAS TRIGGERED EARLIER THAN EXPECTED BY EXTENDED CHARGE TIMES DUE TO A HIGHER-THAN-TYPICAL BUILD-UP OF INTERNAL BATTERY IMPEDANCE. THIS DEVICE IS INCLUDED IN THE MID-LIFE DISPLAY OF REPLACEMENT INDICATORS ((B)(6) 2007) ADVISORY POPULATION.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION, THAT DURING A ROUTINE FOLLOW-UP, THIS PATIENT COLLAPSED, AND WAS UNCONSCIOUS FOR SEVERAL MINUTES. ONCE THE PATIENT WAS CONSCIOUS AGAIN A DEVICE INTERROGATION WAS PERFORMED, WHICH REVEALED THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) REACHED END OF LIFE (EOL). IT WAS UNCERTAIN IF THE PATIENT EXPERIENCED A TACHY ARRHYTHMIA. THE PATIENT REMAINS IN THE HOSPITAL UNTIL A REPLACEMENT PROCEDURE CAN BE PERFORMED. SUBSEQUENTLY, ADDITIONAL INFORMATION WAS RECEIVED THAT THIS ICD WAS EXPLANTED, AND REPLACED WITH A COMPETITOR DEVICE. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 VITALITY 2 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND T177

Patients

Seq Age Sex Outcome Treatment
1 76 YR (B)(4)| (B)(4)| (B)(4)